
"I am glad that taking part in a trial might help others on their own cancer journey.”
Please note - this trial is no longer recruiting patients. We hope to add results when they are available.
This study is looking at using an MRI scan to diagnose bladder cancer that has grown into the muscle.
You may be able to join this study if all of the following apply.
The standard way of diagnosing (pathway 1)
No method of assessing bladder cancer is 100% accurate. For both groups, there is a risk of over or under treatment.
In the standard diagnosis group, there is a small risk that the initial TURBT can show that the tumour hadn’t grown into the muscle wall. But it had. This means these people don't have enough initial treatment or treatment is delayed.
In the newer way of diagnosing there is a small risk of over treatment. This means the scan over estimates the cancer is in the muscle layer of the bladder. So, you have might have treatment that you don’t need. Researchers haven’t done this type of study before. But they predict this might happen in under 5 out of every 100 people (5%).
Having an MRI scan is a safe test. There is a very small chance that you might have an allergic reaction to the contrast medium you have to show up your body organs more clearly. But the person doing the test will keep a close eye on you and treat any problems straight away.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nick James
University of Birmingham
NIHR Health Technology Assessment (HTA) programme
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”